Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scorpius Holdings Inc SCPX

Healthcare Biotechnology
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio... see more

Recent & Breaking News (NYSEAM:SCPX)

18 Biggest Mid-Day Gainers For Monday

Benzinga.com  March 13, 2017

Mid-Day Market Update: AMEC Foster Wheeler Surges Following Wood Group Bid; Aralez Pharmaceuticals Shares Plunge

Benzinga.com  March 13, 2017

Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2

GlobeNewswire March 13, 2017

Heat Biologics to Present at 29th Annual ROTH Conference

GlobeNewswire March 9, 2017

Heat Biologics Announces Agreement to Acquire Pelican Therapeutics

GlobeNewswire March 8, 2017

Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire March 2, 2017

Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium

GlobeNewswire February 17, 2017

Research Reports Initiation on Biotech Stocks -- Heat Biologics, PDL BioPharma, Achaogen, and CEL-SCI

PR Newswire February 16, 2017

Heat Biologics to Present at the Genitourinary Cancers Symposium

GlobeNewswire February 14, 2017

Heat Biologics to Present at NobleCon13

GlobeNewswire January 24, 2017

Research Reports Coverage on Biotech Stocks -- Cara Therapeutics, Heat Biologics, Vanda Pharma, and Opexa Therapeutics

PR Newswire January 10, 2017

Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco

GlobeNewswire January 5, 2017

Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer

GlobeNewswire January 4, 2017

Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results

GlobeNewswire December 6, 2016

Rosen Law Firm Closes Investigation and Concludes There is No Basis for Securities Claims Against HTBX

Business Wire December 1, 2016

Mid-Afternoon Market Update: NASDAQ Down 1.25%; CLARCOR Shares Gain On Acquisition News

Benzinga.com  December 1, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heat Biologics, Inc. (HTBX)

PR Newswire December 1, 2016

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Heat Biologics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire December 1, 2016

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Heat Biologics, Inc. - HTBX

Business Wire December 1, 2016

Heat Biologics Cools Off, Bluebird Bio Heats Up

Benzinga.com  December 1, 2016